Wikidata

(Q43867550)

English

Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes

scientific article published in February 2002

In more languages

Statements

title
Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
author name string
Claus B Juhl
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
Malene Hollingdal
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
Jeppe Sturis
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
Grethe Jakobsen
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
Henrik Agersø
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
Niels Pørksen
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
Ole Schmitz
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
publication date
1 February 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017
page(s)
424-429
1 reference
stated in
Europe PubMed Central
PubMed ID
11812750
retrieved
27 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43867550&oldid=2110155956"